Twist Bioscience (TWST) Financial Analysis & Valuation | Quarter Chart
Twist Bioscience (TWST)
TWSTPrice: $98.36
Fair Value: 🔒
🔒score
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, to... more
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-base... more
Description
Shares
| Market Cap | $6.13B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Emily Marine Leproust |
| IPO Date | 2018-10-31 | CAGR | 0.76% |
| Employees | 923 | Website | www.twistbioscience.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TWST chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.99B | P/E Ratio | -48.22 |
| Forward P/E | -128.86 | PEG Ratio | — |
| P/S Ratio | 1460.66 | P/B Ratio | 1303.2 |
| P/CF Ratio | -10656.48 | P/FCF Ratio | -6281.89 |
| EPS | $-2.04 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 17.77% | Gross Margin | 0.52% |
| Operating Margin | -0.34% | Profit Margin | -0.2% |
| ROE | -0.17% | ROA | -0.12% |
| ROCE | -0.25% | Current Ratio | 2.7 |
| Quick Ratio | 2.42 | Cash Ratio | 1.02 |
| Debt/Equity | 0.21 | Interest Coverage | — |
| Altman Z Score | 13.57 | Piotroski Score | 3 |